UBS's Julian Emanuel weighs in on the healthcare sector after Abbott Laboratories announced plans to buy St. Jude Medical for about $25 billion on Bloomberg Surveillance with Michael McKee and David Gura.
Bloomberg Surveillance
4,199 clip(s)
Single Best Idea with Tom Keene: David Kelly & Lori Calvasina
Bloomberg Surveillance TV: December 22nd, 2025
Markets Eye Tech Turnaround